Jazz Pharmaceuticals plc — Director's Dealing 2020

Dec 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2020-12-04

Reporting Person: Carr Patricia (VP, Finance & PAO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-04	Ordinary Shares	S	62	$152.5479	Disposed	6200	Direct

Footnotes

F1: Includes 62 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 30, 2020.